Peter
Longo
Senior Managing Director, Investments

bio

Peter Longo is senior managing director of investments at CI and has spent over 23 years in numerous roles at CI. Peter is responsible for evaluating investment opportunities, structuring investments and monitoring portfolio companies through active board participation. Peter’s past CI investments include: Achillion Pharmaceuticals (IPO), Cardium Health (acquired by Centene), CYA Technologies (acquired by enChoice), Aventri fka eTouches (acquired by HGGC), NeuVis (acquired by Rational Software), Nufern (acquired by Rofin-Sinar), SilverSky (acquired by BAE Systems), PCC Technology Group (acquired by Clearview Capital) and Post-N-Track.

Peter also serves on the board of the Yale Innovation Fund and serves on the University of Connecticut patent review committee.

connect
education
  • B.S., Business Administration, University of Connecticut
  • M.B.A., University of Hartford

Armed Forces

  • Connecticut Army National Guard

Certifications

  • Certified Public Accountant
  • Chartered Financial Analyst
Companies
  • ActualMeds Corporation (Board Member)
  • Aeromics, Inc (Board Member)
  • Bactana Corp. (Board Member)
  • Continuity Control, Inc. (Board Member)
  • Device42 (Board Member)
  • DiA Imaging Analysis (Board Member)
  • Iridia, Inc. (Board Member)
  • PayVeris LLC (Board Member)
Interesting Facts
  • Favorite place: Yellowstone National Park
  • Favorite hobbies: Hiking, being in the great outdoors